Novel "Carrier-Free" Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis.

Abstract

Paclitaxel (Ptx), a type of microtubule depolymerization inhibitor, is one of the main components in gastric cancer chemotherapy. Some studies have demonstrated that tetrandrine (Tet), a bisbenzylisoquinoline alkaloid, has potential antitumor effects in several cancers. Aside from the direct anticancer effect, Tet is proved to synergistically enhance the antitumor effect of Ptx in gastric cancer. However, the application of the combinational strategy is limited by the poor solubility of both drugs. Nanodrug delivery systems including polymeric nanoparticles, self-assembled nanofibers, hydrogels, etc., hold the potential to meet the need. Here, a novel supramolecular nanomaterial, based on the concept of "carrier-free nanodrugs", is reported as a feasible platform for synergistic drug delivery. Ptx-SA-RGD is obtained through the conjugation of Ptx and the tumor-specific peptide RGD (arginine-glycine-aspartic acid) with succinic acid (SA) as a linker. Ptx-SA-RGD could self-assemble into Ptx nanofibers (P-NFs) with high drug-loading efficiency. Tet was then encapsulated into P-NFs to acquire novel Ptx and Tet coloaded self-assembled nanofibers (P/T-NFs). The uptake study shows the dynamic internalization of P/T-NFs by the gastric cancer cell line MGC-803. P/T-NFs significantly triggered the accumulation of reactive oxygen species (ROS) in gastric cancer cells MGC803 and further decreased the mitochondrial membrane potential, which led to the induction of mitochondrial apoptosis with superior cytotoxicity against free drugs. Moreover, P/T-NFs suppressed the expressions of p-STAT3 and p-JAK, initiated cytochrome-C release, and promoted caspase protein expression. Furthermore, P/T-NFs demonstrated the strongest tumor-delaying effect as well as the lowest toxicity. Therefore, self-assembled nanofibers of P/T-NFs demonstrated an increase of the mitochondrial apoptosis level and a stronger antitumor effect both in vitro and in vivo, which could be a potential way to enhance the clinical efficacy and reduce the side-effects of Ptx in gastric cancer.

• Authors: Xiaolin Li, Na Yu, Jun Li, Jianan Bai, Dan Ding, Qiyun Tang, Huae Xu
• Journal: ACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 12 Issue 9 Pg. 10096-10106 (Mar 04 2020) ISSN: 1944-8252 [Electronic] United States
• PMID: 32027119 (Publication Type: Evaluation Study, Journal Article)

Chemical References

• Antineoplastic Agents
• Benzylisoquinolines
• Drug Carriers
• Reactive Oxygen Species
• tetrandrine
• Paclitaxel

Topics

• Animals
• Antineoplastic Agents (administration & dosage, chemistry)
• Apoptosis (drug effects)
• Benzylisoquinolines (administration & dosage, chemistry)
• Cell Line, Tumor
• Drug Carriers (chemistry)
• Drug Delivery Systems (instrumentation, methods)
• Drug Synergism
• Female
• Humans
• Mice, Nude
• Mitochondria (drug effects, metabolism)
• Nanofibers (chemistry)
• Nanoparticles (chemistry)
• Paclitaxel (administration & dosage, chemistry)
• Reactive Oxygen Species (metabolism)
• Stomach Neoplasms (drug therapy, metabolism, physiopathology)